Fig. 2: Treatment-emergent adverse events of grade ≥ 3 observed in ≥ 10% of patients.

a Dose escalation cohort. b LDAC cohort. Grade 3, severe (green); Grade 4, life-threatening (blue); Grade 5, death (red). Source data are provided as a Source Data file.